Table 4.
Model 3 scores for immunosuppressants and acetylsalicylic acid
| Test | Immunosuppressants | Acetylsalicylic acid | ||||
|---|---|---|---|---|---|---|
| N | β | 95% CI | N | β | 95% CI | |
| MMS | 172 | 0.21 | − 0.10, 0.52 | 1223 | − 015 | − 0.32, 0.02 |
| Digit-symbol coding | 163 | 0.48 | − 1.02, 1.99 | 1176 | − 0.61 | − 1.28, 0.07 |
| Words | 170 | 0.11 | − 0.16, 0.37 | 1217 | − 0.06 | − 0.19, 0.07 |
| Subjective memory | 265 | 0.04 | − 0.11, 0.18 | 1924 | − 0.06 | − 0.13, 0.01 |
| SPPB | 176 | − 0.12 | − 0.45, 0.21 | 1244 | 0.01 | − 0.11, 0.14 |
| Balance | 144 | 0.16 | − 0.56, 0.87 | 1031 | 0.26 | − 0.12, 0.63 |
| Finger-tapping test | 164 | 1.27 | 0.18, 2.36 | 1174 | − 0.42 | − 0.96,0.12 |
| Multivariate test | F = 1.38 | p = 0.21 | F = 1.43 | p = 0.19 | ||
| Grip strength | 173 | − 2.0 | − 3.00, − 0.90 | 1243 | 0.72 | 0.26, 1.18 |
A positive β implies a score above the average of the control group. Differences in β was not statistically significant when 95% CI include both positive and negative limits. The multivariate test examines to what extent the scores of the first seven tests combined are significantly different from the control group; that is, non-users of the medication in question. N number of participants, CI confidence interval, MMS mini-mental state, SPPB short physical performance battery